An open-label, multicohort, phase 1/2 study in patients with virus-associated cancers (CheckMate 358): Safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma of the head and neck (SCCHN) Meeting Abstract
| Authors: | Ferris, R. L.; Gonçalves, A.; Baxi, S. S.; Martens, U. M.; Gauthier, H.; Langenberg, M.; Spanos, W. C.; Leidner, R. S.; Kang, H.; Russell, J.; Chiosea, S.; Soumaoro, I.; Rao, S.; Cao, Z. A.; Topalian, S. |
| Abstract Title: | An open-label, multicohort, phase 1/2 study in patients with virus-associated cancers (CheckMate 358): Safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma of the head and neck (SCCHN) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx440.041 |
| Language: | English |
| ACCESSION: | WOS:000411324005101 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx440.041 |
| Notes: | Meeting Abstract: LBA46 -- Appears on pages 628-629 of the abstract book -- Source: Wos |
